Clinical Scorecard: The Role of Triglyceride-Glucose Index in Predicting Gestational Diabetes Mellitus During Early Pregnancy: Findings from a Prospective Cohort Study
At a Glance
Category
Detail
Condition
Gestational Diabetes Mellitus (GDM)
Key Mechanisms
Elevated Triglyceride-Glucose (TyG) levels in early and mid-pregnancy are independent risk factors for GDM.
Target Population
Pregnant women, particularly those at high risk for GDM.
Care Setting
Clinical settings focusing on maternal-fetal health and diabetes management.
Key Highlights
Incidence of GDM in the study was 13.68%.
Elevated TyG levels in early and mid-pregnancy are significant risk factors for GDM.
A progressive increase in TyG levels throughout pregnancy correlates with GDM risk.
Guideline-Based Recommendations
Diagnosis
Screening for GDM is recommended between 24 and 28 weeks of gestation.
Management
Interventions to reduce maternal hyperglycemia should start at diagnosis.
Monitoring & Follow-up
Monitor TyG levels in early pregnancy for risk assessment.
Risks
GDM increases risks of maternal and fetal complications.
Patient & Prescribing Data
Pregnant women, especially those with risk factors for GDM.
Early detection and management of GDM can improve pregnancy outcomes.
Clinical Best Practices
Utilize TyG index for early risk prediction of GDM.
Implement lifestyle interventions in high-risk women before or early in pregnancy.
